Peptide synthesis explained: pathways & solid-phase synthesis

Peptide synthesis is the purposeful construction of a precisely defined amino acid sequence. This page focuses mainly on chemical synthesis in the lab: first the basic principle, then the differences between ribosomal, nonribosomal and chemical formation, and finally the Merrifield solid-phase synthesis as the standard method. A glossary for research peptides helps with key terms. For many research peptides, this exact production route is relevant; what is covered here is the process itself, not a recommendation for use in humans.

How individual amino acids become a defined sequence

In peptide synthesis, individual amino acids are linked in a defined order via peptide bonds. In chemical peptide synthesis, this happens stepwise from prepared building blocks and under controlled reaction conditions. What matters is not just that a peptide forms, but that sequence, length and modifications are planned exactly and built up reproducibly.

Ribosomal, nonribosomal or chemical: comparing the pathways

Merrifield synthesis: the solid-phase synthesis standard

In Merrifield peptide synthesis, the growing chain remains bound to an insoluble solid support. This solid-phase principle facilitates repeated reaction cycles because excess reagents and byproducts can be washed away between steps. Resin, linker, protected amino acids and standardized washing steps still form the basis of many SPPS workflows today.

Starting on the support: first amino acid and protecting groups

First, the initial amino acid in protected form is attached to the resin via a linker. This firmly anchors the starting point of the later sequence. The N-protecting group is then removed so the next amino acid can react. Common protecting-group strategies are Boc and Fmoc chemistry, which limit side reactions during assembly that are relevant to the eventual peptide purity.

Coupling and chain elongation: the recurring synthesis cycle

In each cycle, an activated amino acid reacts with the free N-terminus of the growing chain. Classic coupling reagents such as DCC increase the reactivity of the carboxyl group and enable the peptide bond. Washing steps then follow, renewed deprotection and repetition of the same pattern until the planned sequence is fully built.

Cleavage from the resin: when the peptide is released

After the final coupling step, the assembled peptide is released from the solid support. The conditions required depend on the resin, linker and chosen protecting-group strategy. Classical Merrifield descriptions mention strong cleavage reagents such as hydrogen fluoride; modern solid-phase protocols vary here depending on the system used and the target molecule.

Why the Merrifield method changed peptide chemistry

Robert Bruce Merrifield made peptide synthesis much more systematic through the solid-phase principle. Instead of isolating each intermediate individually, reaction cycles can be standardized and partially automated. Further solid-phase variants evolved from this basic principle, including SPOT approaches for screening and mapping applications in research and development.

What chemical peptide synthesis can do – and where its limits lie

Chemical solid-phase synthesis is readily automatable and is particularly suitable for deliberately designed short to medium-length sequences, analogs and many research peptides. The solid support simplifies intermediates through efficient washing steps. However, as chain length increases, cumulative losses, side reactions and the effort required for purification also increase. Therefore, in addition to the synthesis route, analytics and batch documentation are important. At 24Peptides we provide COAs for every batch, because "chemically synthesized" alone says nothing about identity, purity or impurities. Anyone who wants to understand a COA for peptides needs exactly this information.

Frequently asked questions about peptides and peptide synthesis

Questions about peptide synthesis often arise that mix chemical fundamentals, legal situation and possible applications. The answers below deliberately separate these layers from one another.

Should you take peptides?

That cannot be answered in general terms. There are major differences in evidence, regulation and risk profile between approved medicines, dietary supplements and pure research peptides. Whether an application in humans is sensible or safe is a medical question. The type of synthesis alone says nothing about suitability. Research peptides from 24Peptides are intended solely for research purposes and not for human use.

Are peptides legal in Germany?

That depends on the specific peptide, the intended use, and on supply, marketing and import. Depending on the substance, pharmaceutical law, chemicals law, anti-doping law and consumer protection can be relevant in parallel. Research substances do not automatically have the same status as approved drugs or cosmetic raw materials. For a reliable classification, the individual case should always be reviewed legally.

Is a peptide a protein?

Peptides and proteins both consist of amino acids but usually differ in length and structural complexity. Shorter chains are usually referred to as peptides, longer and more highly folded chains more often as proteins. There is no universal hard cutoff; the terms are used somewhat differently depending on discipline and context.

Who produces peptides?

Peptides are produced by specialized chemical and biotech companies, pharmaceutical manufacturers, contract manufacturers and, in part, also in academic laboratories. Short, defined sequences are often produced chemically via solid-phase synthesis. Larger or more complex products can be produced biologically. Which type of producer suits B2B peptide sourcing depends on the target molecule, the scale and the regulatory framework.